Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Exchange Rate Effect (2016 - 2025)

Bio-Techne has reported Exchange Rate Effect over the past 17 years, most recently at $413000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $413000.0 for Q4 2025, up 107.55% from a year ago — trailing twelve months through Dec 2025 was $11.5 million (up 344.39% YoY), and the annual figure for FY2025 was $11.9 million, up 611.23%.
  • Exchange Rate Effect for Q4 2025 was $413000.0 at Bio-Techne, up from -$1.2 million in the prior quarter.
  • Over the last five years, Exchange Rate Effect for TECH hit a ceiling of $13.4 million in Q2 2025 and a floor of -$11.9 million in Q3 2022.
  • Median Exchange Rate Effect over the past 5 years was -$465500.0 (2021), compared with a mean of -$282950.0.
  • Biggest five-year swings in Exchange Rate Effect: crashed 4548.67% in 2022 and later soared 569.18% in 2024.
  • Bio-Techne's Exchange Rate Effect stood at $3.1 million in 2021, then surged by 138.86% to $7.3 million in 2022, then tumbled by 53.4% to $3.4 million in 2023, then plummeted by 259.74% to -$5.5 million in 2024, then skyrocketed by 107.55% to $413000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $413000.0 (Q4 2025), -$1.2 million (Q3 2025), and $13.4 million (Q2 2025) per Business Quant data.